{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:55:52Z","timestamp":1791327352594,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015317","name":"Translational Research Institute, University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","award":["KL2 TR003108\/UL1 TR003107"],"award-info":[{"award-number":["KL2 TR003108\/UL1 TR003107"]}],"id":[{"id":"10.13039\/100015317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA236209"],"award-info":[{"award-number":["R01CA236209"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R24GM137786"],"award-info":[{"award-number":["R24GM137786"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["P20GM139768"],"award-info":[{"award-number":["P20GM139768"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008276","name":"College of Medicine, University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.molimm.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:04:23Z","timestamp":1697137463000},"page":"188-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma"],"prefix":"10.1016","volume":"163","author":[{"given":"Lauren C.","family":"Morehead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Koss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billie","family":"Heflin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine F.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Tackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle R.","family":"Miousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2023.10.003_bib1","first-page":"40","article-title":"Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol","author":"Ashrafizadeh","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.molimm.2023.10.003_bib2","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.18632\/oncotarget.3372","article-title":"Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective","volume":"6","author":"Burks","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.molimm.2023.10.003_bib3","first-page":"9","article-title":"Interferon-Gamma at the crossroads of tumor immune surveillance or evasion","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.10.003_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3390\/molecules26051343","article-title":"Recent advancements on immunomodulatory mechanisms of resveratrol in tumor microenvironment","volume":"26","author":"Chhabra","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.molimm.2023.10.003_bib5","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.molimm.2023.10.003_bib6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1158\/2326-6066.CIR-19-0229","article-title":"STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity","volume":"7","author":"Falahat","year":"2019","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.molimm.2023.10.003_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2023.10.003_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","article-title":"Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence","volume":"179","author":"Harel","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molimm.2023.10.003_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","article-title":"The development of STING agonists and emerging results as a cancer immunotherapy","volume":"25","author":"Hines","year":"2023","journal-title":"Curr. Oncol. Rep. Mar."},{"key":"10.1016\/j.molimm.2023.10.003_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00018-010-0605-2","article-title":"The STING pathway and regulation of innate immune signaling in response to DNA pathogens","volume":"68","author":"Ishikawa","year":"2011","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.molimm.2023.10.003_bib11","first-page":"12","article-title":"Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma","author":"Kalbasi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molimm.2023.10.003_bib12","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-20-0524","article-title":"Epigenetic control of Cdkn2a.Arf protects tumor-infiltrating lymphocytes from metabolic exhaustion","volume":"80","author":"Koss","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2023.10.003_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5483\/BMBRep.2013.46.4.033","article-title":"Caloric restriction and its mimetics","volume":"46","author":"Lee","year":"2013","journal-title":"BMB Rep."},{"key":"10.1016\/j.molimm.2023.10.003_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd4391","article-title":"Caloric restriction mimetics: towards a molecular definition","volume":"13","author":"Madeo","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molimm.2023.10.003_bib15","series-title":"Cutaneous Melanoma: Etiology and Therapy","article-title":"Epidemiology of Melanoma","author":"Matthews","year":"2017"},{"key":"10.1016\/j.molimm.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/molecules26010229","article-title":"Anti-Inflammatory action and mechanisms of resveratrol","volume":"26","author":"Meng","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.molimm.2023.10.003_bib17","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"Nesvizhskii","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.molimm.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41579-018-0020-5","article-title":"ISG15 in antiviral immunity and beyond","volume":"16","author":"Perng","year":"2018","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.molimm.2023.10.003_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molimm.2023.10.003_bib20","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/ijms21062084","article-title":"Potential adverse effects of resveratrol: a literature review","volume":"21","author":"Shaito","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2023.10.003_bib21","first-page":"4266","article-title":"Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy","volume":"130","author":"Such","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molimm.2023.10.003_bib22","first-page":"8","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","author":"Suraweera","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molimm.2023.10.003_bib23","doi-asserted-by":"crossref","unstructured":"Smith JA. STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation? Front Immunol. 2021 Jan 21;11:611347. doi: 10.3389\/fimmu.2020.611347.","DOI":"10.3389\/fimmu.2020.611347"},{"key":"10.1016\/j.molimm.2023.10.003_bib24","article-title":"No longer a one-trick pony: STING signaling activity beyond interferon","volume":"434","author":"Wu","year":"2022","journal-title":"J. Mol. Biol. Multifaceted Innate Response Virus Infect."},{"issue":"115\u2013126","key":"10.1016\/j.molimm.2023.10.003_bib25","article-title":"Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion","volume":"53","author":"Wu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2023.10.003_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/mol.104.006023","article-title":"Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma","volume":"67","author":"Yang","year":"2005","journal-title":"Mol. Pharmacol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902300202X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902300202X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:52:09Z","timestamp":1777492329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158902300202X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"alternative-id":["S016158902300202X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2023.10.003","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}